These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810 [TBL] [Abstract][Full Text] [Related]
28. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Casey DE Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453 [TBL] [Abstract][Full Text] [Related]
29. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial. Lee JG; Shin BS; Lee YC; Park SW; Kim YH Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029 [TBL] [Abstract][Full Text] [Related]
34. Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Nasrallah HA Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454 [TBL] [Abstract][Full Text] [Related]
36. Propranolol in the treatment of tardive dyskinesia. Perényi A; Farkas A Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627 [No Abstract] [Full Text] [Related]
37. The clinical association of tardive dyskinesia and drug-induced parkinsonism. Wolf ME; Chevesich J; Lehrer E; Mosnaim AD Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032 [No Abstract] [Full Text] [Related]
38. A five year follow-up study of tardive dyskinesia. Chouinard G; Annable L; Mercier P; Ross-Chouinard A Psychopharmacol Bull; 1986; 22(1):259-63. PubMed ID: 2873614 [No Abstract] [Full Text] [Related]
39. [30 years of neuroleptics--time for critical discussions]. Modestin J Dtsch Med Wochenschr; 1983 Sep; 108(38):1446-51. PubMed ID: 6136400 [No Abstract] [Full Text] [Related]